RSS   Newsletter   Contact   Advertise with us

10,000 volunteers: Novavax coronavirus vaccine enters late stage trials in UK

Christian Fernsby ▼ | September 25, 2020
Novavax has announced it is starting its Phase 3 trial of an experimental coronavirus vaccine in the UK.
Volunteers   Novavax
Up to 10,000 volunteers aged between 18 and 84 will be enrolled for the study, which is set to take place over the next four to six weeks and marks the final step of the regulatory approvals process.

Topics: Novavax

Half of the volunteers will receive two shots of NVX-CoV2373 with Matrix-M, Novavax's adjuvant, which is meant to strengthen the vaccine. The other participants will be given a placebo.